Astellas Pharma Inc 2023 Integrated Report
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Integrated Report
Pages: 100
The report describes Astellas' FY2022 performance and value-creation strategy, including consolidated revenue of ¥1,518.6 billion. It highlights a new Sustainability Direction, progress on Access to Health, and a commitment to achieve net-zero GHG emissions by 2050. Environmental disclosures report FY2022 Scope 1 and 2 emissions of 117,644 tons and Scope 3 emissions of 445,007 tons, while renewable energy represented 19% of total energy use. The report also records 14,484 consolidated employees and 30% female directors.
Services
From bulk PDFs to structured indicators and machine-readable documents.